HIGHLIGHTS
SUMMARY
The study lot was split based on cognitive function into an active subgroup of 118 cognitively impaired patients and a control subgroup of 44 patients with normal cognitive status. The patients` cognitive statuses defined the allocation of cases into two study subgroups: one consisting of 118 patients with cognitive impairment (either mild, moderate, or severe) and another consisting of 44 patients-defined as the control group-with normal cognitive function. When evaluating the association of cognitive impairment status within the categories of plasma deficiency of 25(OH)D in the study cohort, the measurements . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.